Filed under: General Problems | Leave a Comment »
https://www.medpagetoday.com/special-reports/features/108846
Survey results released today contradict widely-held beliefs that Medicare Advantage enrollees are more satisfied because they receive better health services than those in traditional Medicare.
On the contrary, respondents in the two types of Medicare plans reported equal satisfaction, although more Medicare Advantage (MA) enrollees than traditional Medicare (TM) beneficiaries said their care was delayed because of the need for prior approval. This trend sheds light on potential considerations for those exploring Medicare Advantage plans 2024.
The reportopens in a new tab or window by The Commonwealth Fund analyzed responses from 3,280 Medicare beneficiaries between November 6, 2023, and January 4 in an effort to learn “What Do Medicare Beneficiaries Value About their Coverage?” Those surveyed gave their opinions on the ease of their access to benefits, care coordination, services, and satisfaction.
“Overall, the experiences seem to be similar for those in traditional Medicare versus Medicare Advantage, with some notable exceptions,” Gretchen Jacobson, PhD, vice president of Commonwealth’s Medicare program, told MedPage Today.
The comparison of beneficiary experiences in each model is important because roughly half, or 52% of 66 million eligible people, are now enrolled in MA plans, to which federal funds pay billions more than for TM care. In 2024, for example, MA plans are expected to receive $88 billionopens in a new tab or window more than what would have been spent if the same people were in TM.
Although there are efforts underway to contain that spending through new payment policiesopens in a new tab or window, MA enrollment is projected to continue rapid growth. So it’s important that taxpayers understand what they’re getting for all that extra money.
A perhaps surprising finding of the survey was MA enrollees’ relatively low use of their “extra benefits,” such as vision, hearing, and dental care, considering that plans aggressively market these benefits to encourage signups. Jacobson noted that Medicare pays the plans $1,915 a year per enrollee for these benefits, according to the 2023 annual reportopens in a new tab or window from the Medicare trust funds’ trustees. These extras are not covered under TM.
For example, 31% of MA enrollees hadn’t used any of their benefits in the last 12 months, 58% hadn’t used dental benefits, 59% hadn’t used vision benefits, 93% hadn’t used hearing benefits, 81% hadn’t used the gym membership, and 54% hadn’t used their over-the-counter medication allowance. Other benefits such as meal delivery and an allowance for groceries may be less frequently offered by the plans, but 98% and 88%, respectively, said they hadn’t used them.
“Because this is an important component of what Medicare Advantage plans are offering, we need to understand better why they aren’t using them, and whether these are the benefits people really want,” she said.
For those who hadn’t used any benefits, 63% of respondents said they didn’t need them, 24% said they didn’t know what benefits the plans offered, 9% said the benefits were hard to use, and 4% said the costs were too high.
Some underlying reasons for the low rates of use, not specified in the report, could be because of restrictions. Perhaps the networks or setting one would have to use — for example, a group of dentists — excludes one who has long served the family. But it also might be because enrollees don’t know about them or forgot about them, despite the ubiquitous advertisingopens in a new tab or window that prominently pitches them.
A CMS proposed ruleopens in a new tab or window would, if finalized, require MA plans to send mid-year notices to enrollees about any unused benefits, to “ensure MA plans are better stewards of the rebate dollars directed towards these benefits,” the proposed rule says.
A big selling point for MA plans is that their providers cooperate within carefully picked integrated networks and coordinate care far better than providers who treat TM beneficiaries.
But here, the survey responses revealed another contradiction. Regardless of whether they had an MA or a TM plan, about an equal number of respondents said they coordinate their healthcare services themselves: 75% in MA and 73% in TM.
Some 7% of people on MA said their plan helps to coordinate their care, Jacobson said. “It seems as though the plans are certainly not the primary care coordinator for most Medicare Advantage enrollees.”
Jacobson acknowledged that MA plan providers might be coordinating their patients’ care in ways enrollees aren’t aware. “But from the beneficiaries’ perspective, they don’t see their plan having a large role in coordinating care.”
Another counterintuitive finding is that a similar percentage of MA and TM respondents said they waited more than one month to see a doctor (36% and 34%), perhaps suggesting that MA enrollees do not get faster access for appointments. “Access to providers seems to be similar, which is counter to some thoughts around the limitations around provider networks,” Jacobson said.
Of the MA plan respondents, 22% said their care was delayed because it required approval, compared with 13% of TM beneficiaries. Far fewer services under TM require pre-approval compared with MA, so it was unclear why so many TM beneficiaries encountered obstacles.
Another surprise was that a larger share of people in MA said they had problems affording care compared with people in TM, “which is contrary to how we typically think of Medicare Advantage,” Jacobson said. “It doesn’t appear that Medicare Advantage plans are necessarily making care more affordable for people.”
Similar percentages of the two beneficiary groups also said their benefits do not cover what they needed, that they were unsure of what benefits they had, that costs were too high, and that they need transportation to access benefits.
Jacobson noted that if Medicare pays more per capita to MA plans than for TM care, it results in higher Part B premiums to all beneficiaries, regardless of what type of plan they’re in. Most frequently, the premium is paid through an amount withheld from their social security retirement benefit checks.
Another finding of note evaluated health risk assessments both types of Medicare patients received in the last year. Of those who received them, few said it caused their doctor to change their care or led to more services or benefits. Only 6% of both MA and TM beneficiaries said their doctor changed their care plan as a result.
“This really calls into question the value that these assessments are providing to beneficiaries and what frequency it’s important to have them,” Jacobson said.
Asked if the survey responses may raise questions about whether MA plans are worth their extra cost, Jacobson replied: “What our survey shows is that the experiences people report seem to be similar overall for those in Medicare Advantage versus traditional Medicare.”
That, she said, makes it “worth assessing the relative value of care and benefits people in Medicare Advantage and traditional Medicare are receiving relative to the amount spent by the federal government. This is worth keeping an eye on as enrollment in Medicare Advantage grows.”
Because it’s well known that Medicare recipients are frequently confused over what kind of coverage they have, the plan type was verified through Zoom calls in which respondents showed their plan card.
Filed under: General Problems | 1 Comment »
Bob and I became friends after someone convinced me to join the APDF’s BOD, some 4-5 yrs ago. Bob has very good intentions. Like many other chronic painers who are also advocates, many practitioners have built-in biases about taking advice about pain management from someone who does not have a medical background. Often they are viewed as supporting prescribing a controlled substance and/or advocating against some of the medications that are prescribed off-label for pain. While Bob’s batting average is not a 1000 on advocating for chronic pain pts, no one’s is. Because of Bob, there is a large number of end-stage pediatric cancer pts who had a less painful last few days/weeks/months of their life and parents who did not have to see their kids live in agony the last days/weeks/months and they had many “extra days” with their kid.
Filed under: General Problems | Leave a Comment »
Most of the “facts” in this video are true. One false statement – the top 4-5 PBM are now owned by the larger insurance companies. The PBM industry was created from a UAW union contract in late 1969 when they wanted a more standardized way for union members to submit their Rx receipts for reimbursement of Rxs that they had paid for. Somewhere between then and now, these PBMs became licensed insurance companies.
Back in the 1940s, Congress gave insurance companies an exemption to the Sherman Antitrust Act https://en.wikipedia.org/wiki/McCarran%E2%80%93Ferguson_Act. Back in the day, the DOJ told pharmacies they could not create an entity to negotiate reimbursements from a PBM, that was “price fixing”.
At one time, the PBM contracts with Pharmacies PROHIBITED pharmacies from telling pts if their cash price was less than the copay their PBM wanted them to pay, if the pt asked if the pharmacy’s cash price was less than the PBM copay, the pharmacist was allowed to tell the pt the true about the cash price that the pt could pay. During the Trump administration either Trump did an EO or Congress passed a law that made it illegal for such clauses to be in the PBM contract.
Actually, it was our Congress that gave the PBMs the idea of getting kickbacks, discounts, and rebates. In the early 70s, Congress decided that because the Feds spent so much on medications on Medicaid Rxs. The Federal government deserved a 10% discount/rebate/kickback from the pharmas for any Rx paid for by Medicaid.
It would appear that since the insurance/PBM industry has one of the largest pots of money to lobby Congress, it would seem that all that money spread around Congress, that industry gets Congress to give them what they want.
Filed under: General Problems | Leave a Comment »
It has been almost 60 years since I pursued a pharmacy degree. That is almost 3 generations ago. Only one out of 5-6 freshmen declared pharmacy majors at Butler U, made it to graduation, and only ONE out of my class failed to pass the “boards” on the first attempt. Back 10-15 yrs ago, pharmacy schools were getting 5-6 applications for every open pharmacy school slot.
I have heard that pharmacy schools are now accepting 90% of applicants and looking at the graduation rates. It would appear that only 1 out of 2 applications make graduation and 20% – 25% of the grads won’t pass the boards on the first attempt.
Back in the day, the number of pharmacy schools was in the low 80’s, today there are 144 schools. Indiana had 2 pharmacy schools – Butler U & Purdue U and today a third pharmacy school Manchester U.
In the articles below on the percentage of grads that passed the NAPLEX boards on the first attempt. Only Butler U – my alma mater – showed up in the top 12 of the percentage of grads passed on the first attempt.
Will pts benefit from all these changes or end up being more poorly taken care of? Only time will tell.
https://www.axios.com/2024/02/06/pharmacy-staffing-shortage-burnout
The big picture: There’s been a steady drop in applications to pharmacy schools, falling 64% from nearly 100,000 in 2012 to about 36,000 in 2022, according to the American Association of Colleges of Pharmacy.
In 2022, there were 13,323 graduates from four-year pharmacy programs, down from 14,223 the previous year and the largest drop since 1983, per AACP data.
https://www.beckershospitalreview.com/pharmacy/top-15-pharmacy-schools-by-naplex-pass-rates.html
The average all-time pass rate of the North American Pharmacist Licensure Examination was 75.7% in 2023 — a slight increase from the year prior, according to data from the National Association of Boards of Pharmacy.
In 2021, the first-time pass rate was 81.3%, and subsequent years have dropped to about 77%. For all-time passes, 2021 recorded 77.3%, 2022 saw 73.9% and 2023 saw 75.7%.
https://www.beckershospitalreview.com/pharmacy/top-20-pharmacy-schools-by-naplex-passing-rates.html
Filed under: General Problems | Leave a Comment »